Consolidated Statements of Shareholders Equity (Deficit) - USD ($)	Common Stock	Additional Paid-In Capital	Accumulated Deficit	Total
Beginning balance, shares at Dec. 31, 2017	38,983,327
Beginning balance, value at Dec. 31, 2017	$ 38,983	$ 1,579,401	$ (1,539,721)	$ 78,663
Acquisition of Herelab, shares	1,650,000
Acquisition of Herelab, value	$ 1,650	493,350		495,000
Benefical conversion feature discount on note payable		500,000		500,000
Net loss			(689,664)	(689,664)
Ending balance, shares at Jun. 30, 2018	40,633,327
Ending balance, value at Jun. 30, 2018	$ 40,633	2,572,751	(2,229,385)	383,999
Beginning balance, shares at Mar. 31, 2018	40,633,327
Beginning balance, value at Mar. 31, 2018	$ 40,633	2,572,751	(1,799,554)	813,830
Net loss			(429,832)	(429,832)
Ending balance, shares at Jun. 30, 2018	40,633,327
Ending balance, value at Jun. 30, 2018	$ 40,633	2,572,751	(2,229,385)	383,999
Beginning balance, shares at Dec. 31, 2018	40,633,327
Beginning balance, value at Dec. 31, 2018	$ 40,633	2,572,751	(3,153,020)	(539,636)
Stock-based compensation, shares	1,612,602
Stock-based compensation, value	$ 1,613	216,595		218,208
Discount on notes payable		38,222		38,222
Net loss			(1,327,041)	(1,327,041)
Ending balance, shares at Jun. 30, 2019	42,245,929
Ending balance, value at Jun. 30, 2019	$ 42,246	2,827,568	(4,480,061)	(1,610,247)
Beginning balance, shares at Mar. 31, 2019	41,810,323
Beginning balance, value at Mar. 31, 2019	$ 41,810	2,780,087	(3,933,058)	(1,111,161)
Stock-based compensation, shares	435,606
Stock-based compensation, value	$ 436	47,481		47,917
Net loss			(547,003)	(547,003)
Ending balance, shares at Jun. 30, 2019	42,245,929
Ending balance, value at Jun. 30, 2019	$ 42,246	$ 2,827,568	$ (4,480,061)	$ (1,610,247)